Antipsychotic Polypharmacy in Treatment of Schizophrenia; Should or Should Not?
Chi-Un PAE.
Chonnam Medical Journal
; : 157-165, 2020.
ArtÃculo | WPRIM | ID: wpr-831242
Documentos relacionados
Antipsychotic Polypharmacy in Treatment of Schizophrenia; Should or Should Not?
Polypharmacy Management of Antipsychotics in Patients with Schizophrenia.
[Tick-borne disease or not? Do not let yourself be fooled].
Clinical Outcomes after Clozapine Discontinuation in Patients with Schizophrenia: A Systematic Review.
[Prevention and treatment of antipsychotic induced weight gain].
Metabotropic Glutamate Receptors As Emerging Targets for the Treatment of Schizophrenia.
[Kirschner wire osteosynthesis for fractures in childhood: bury wires or not? : Results of a survey on care reality in Germany].
Long-term treatment of bipolar disorder type I: A systematic and critical review of clinical guidelines with derived practice algorithms.
How and when to treat the most common adverse effects of antipsychotics: Expert review from research to clinical practice.
Optimising plasma clozapine levels to improve treatment response: an individual patient data meta-analysis and receiver operating characteristic curve analysis.